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Summary
We investigated the hypothesis that gene expression
proﬁles in cultured cell lines from adults, aged 57–
97 years, contain information about the biological age
and potential longevity of the donors. We studied 104
unrelated grandparents from 31 Utah CEU (Centre
d’Etude du Polymorphisme Humain – Utah) families, for
whom lymphoblastoid cell lines were established in the
1980s. Combining publicly available gene expression
data from these cell lines, and survival data from the
Utah Population Database, we tested the relationship
between expression of 2151 always-expressed genes,
age, and survival of the donors. Approximately 16% of
2151 expression levels were associated with donor age:
10% decreased in expression with age, and 6%
increased with age. Cell division cycle 42 (CDC42) and
CORO1A exhibited strong associations both with age at
draw and survival after draw (multiple comparisons-
adjusted Monte Carlo P-value < 0.05). In general, gene
expressions that increased with age were associated
with increased mortality. Gene expressions that
decreased with age were generally associated with
reduced mortality. A multivariate estimate of biological
age modeled from expression data was dominated by
CDC42 expression, and was a signiﬁcant predictor of
survival after blood draw. A multivariate model of sur-
vival as a function of gene expression was dominated
by CORO1A expression. This model accounted for
approximately 23% of the variation in survival among
the CEU grandparents. Some expression levels were
negligibly associated with age in this cross-sectional
dataset, but strongly associated with inter-individual
differences in survival. These observations may lead to
new insights regarding the genetic contribution to
exceptional longevity.
Key words: aging; cell cycle; cell lines; CEU; gene
expression; longevity.
Introduction
Systematic genome-wide screens for engineered gene expres-
sion changes that increase lifespan have identiﬁed scores of
‘longevity genes’, by deletion in yeast (Powers et al., 2006),
RNA interference in Caenorhabditis elegans (Hamilton et al.,
2005), and activation of expression in Drosophila (Seong
et al., 2001). Therefore, we hypothesized that natural inter-
individual variation in gene expression in human populations
may be associated with signiﬁcant differences in survival. We
investigated the possibility that shifts in expression levels of
single genes (or combinations of genes) may have broad
health beneﬁts in late middle and old age, by lowering the
risk of mortality. Such effects would be expected for genes
that regulate the rate of progression of fundamental
processes of senescence.
The CEPH⁄Utah (CEU) family resource, maintained at the
Coriell Cell Repositories in Camden, NJ, USA (http://ccr.coriell.
org/Sections/Collections/NIGMS/CEPHFamilies.aspx?PgId=49&
Coll=GM), consists of Epstein–Barr virus-immortalized lympho-
blastoid cell lines and DNA extracted there from, for 46 three-
generation CEU families, each consisting of 5–15 siblings,
their two parents, and two to four grandparents who were
still alive at the time of the family blood draws in the early
1980s (White et al., 1985; Dausset et al., 1990). Cell lines
from 153 CEU grandparents are available from Coriell. In
addition, approximately 20 years of follow-up data (survival
and mortality) are available for 145 of the 153 Utah grandpar-
ents from the Utah Population Database (UPDB) and the Utah
Genetic Reference Project at the University of Utah.
Several recent papers examining the genetics of gene
expression levels in the CEU cell lines (Cheung & Spielman,
2002; Cheung et al., 2003, 2005; Schadt et al., 2003; Monks
et al., 2004; Morley et al., 2004; Stranger et al., 2005) have
conﬁrmed, by familial correlation, linkage, and⁄or genetic
association, that a substantial portion of the variability in gene
expression levels is under genetic control. Thus, prior evidence
has established that a major source of variation in expression
levels in the CEU cell lines is genetic differences among indivi-
duals, rather than variation in the conditions of tissue culture,
cell transformation, or storage and handling of the samples.
In this context, it is reasonable to test for associations
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lbetween gene expression proﬁles in these cell lines and genet-
ically inﬂuenced complex traits in their donors.
To date, two genome-wide studies of longevity in humans
have been published (Puca et al., 2001; Lunetta et al., 2007),
and several additional studies are currently in progress. Puca
and colleagues performed a sib-pair linkage study of cente-
narians and near centenarians, and identiﬁed a region of
interest on chromosome 4q25. Subsequent work by this
group led to the conclusion that one or more variants of
microsomal triglyceride transfer protein (Geesaman et al.,
2003) were responsible for this effect, although other groups
have failed to conﬁrm this association (Nebel et al., 2005;
Beekman et al., 2006). More recently, the ﬁrst genome-wide
association study of longevity and correlates of longevity
found numerous associations with nominal P-values of 0.001
or less, including some candidate genes such as FOX1a, but
none that clearly exceeded a threshold allowing for multiple
hypothesis testing (Lunetta et al., 2007).
In this paper, we report on the association between age at
blood draw and expression levels for 2151 always-expressed
genes in the CEU cell lines. We use these data to construct an
estimate of biological age based on gene expression levels,
then use our biological age estimate in a proportional hazards
model of survival after blood draw to assess the degree to
which gene expression proﬁles can serve as biomarkers of
aging and⁄or longevity. We further test how well a multivari-
ate survival model based on age-adjusted gene expression
predicts mortality among the CEU grandparents. Our
approach is not speciﬁcally designed to identify heritable vari-
ants that affect longevity. Rather, we are searching for stable
variation in gene expressions that affect or mark longevity.
We anticipate that inherited genetic variants, including copy
number variants, account for much of the variation in gene
expression, although it is likely that epigenetic factors may
also play a large role (Mathers, 2006).
Results
Changes in gene expression with age: CEU
grandparents
If the expression of a gene responds to the progress of senes-
cence by rising or falling over the adult lifespan, then expres-
sion differences among chronologically age-matched adults
may reﬂect variation in rates of biological aging. To establish
age-related changes in gene expression levels, we ﬁrst identi-
ﬁed expressions most strongly associated with age at blood
draw. Of the 8793 total measured expressions (probesets on
Affymetrix HG-Focus arrays), we used only the 2151 always-
expressed genes (in all 362 cell lines and three generations of
Utah CEU families), to examine the relationship between indi-
vidual expression levels and age at draw in the CEU grandpar-
ent cell lines. We modeled expression as a simple linear
function of age at draw. Expression levels are reported on a
log2 scale, so that a linear increase or decrease in measured
expression level corresponds to a multiplicative increase in
gene expression. Because the grandparents were effectively
unrelated to one another, no adjustment for kinship was nec-
essary, and conventional linear regression models were used.
A more complex analysis of changes in gene expression
with age over all three generations of CEU families revealed a
large number of highly signiﬁcant associations. However,
interpretation of age-related changes in expression across
three generations, ages 5–97, is difﬁcult because senescence
can be confounded with sexual or physiological maturation,
as well as secular trends occurring over such a long span of
donor birth years in these families. Methods and results of this
analysis are described in the Supporting Information.
Of the 2151 always-expressed genes, 345 (16%) expres-
sions were associated with age at draw in the CEU grandpar-
ents at a nominal P < 0.05. Of these, 125 increased with age
and 220 decreased with age. Table 1 shows the magnitude,
direction, and signiﬁcance of the linear regression of expres-
sion as a function of age at draw for the top ten age-associ-
ated expression levels for the 104 CEU grandparents, after
adjusting for sex. None of the always-expressed genes was
linearly associated with age at draw at a nominal P-value
below the Bonferroni 5% threshold of 2.3 · 10
)5. The stron-
gest association of expression level with age was CDC42 (cell
division cycle 42), which exhibited strongly increased expres-
sion with age, with a sex-adjusted P-value of 3.1 · 10
)5, and
an unadjusted P-value of 1.3 · 10
)5. Among the ten most
strongly age-associated expression levels (Table 1), equal
numbers (ﬁve) increase and decrease with age. Table S3 (Sup-
porting Information) shows complete results for the 2151
always-expressed genes.
Also shown in Table 1 is the estimated heritability of expres-
sion (H
2) for each gene listed, and the correlation of expres-
sion between spouses. Most of the genes listed in Table 1
have heritabilities between 0.2 and 0.5. CORO1A has the
Table 1 Top ten age-associated expression levels in CEU grandparents
HG-focus
probeset
Gene
symbol ZP -value H
2
Spouse
correlation
HF6524 CDC42 4.36 3.14E)05 0.26 0.062
HF2432 MKNK2 4.09 8.65E)05 0.35 0.12
HF8737 SH3BGRL 4.07 9.51E)05 0.45 )0.057
HF4113 RNH1 )4.03 1.09E)04 0.00 )0.010
HF6098 TMEM142C 3.75 2.97E)04 0.09 )0.13
HF7682 CDC6 )3.73 3.13E)04 0.33 0.28
HF1646 USP1 )3.65 4.23E)04 0.23 0.055
HF1405 EDF1 3.60 4.88E)04 0.27 )0.028
HF982 QDPR )3.60 5.01E)04 0.28 0.029
HF7873 CORO1A )3.49 7.19E)04 0.66 0.23
Probeset, probeset name from HG-focus refseq transcript library [see
reference (Liu et al., 2007)]; gene symbol(s), HUGO symbol name or names
corresponding to current mapping of probeset sequence; Z, Z-score of
linear model of expression vs. age, adjusted for sex; P-value, probability of
observing a Z greater than that observed under the null hypothesis; H
2,
heritability.
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240highest estimated heritability (0.66), while expression levels
for RNH1 and TMEM142C do not appear to be heritable.
Spouse correlations are generally very low, with moderate
positive correlations observed for CDC6 (0.28) and CORO1A
(0.23).
Proportional hazards models of survival vs. gene
expression
We also tested for gene expressions most strongly associated
with survival, independently of their associations with age at
blood draw. Table 2 shows the ten strongest associations
between age-adjusted expression and survival after blood
draw among the 104 CEU grandparents. Corresponding data
for all genes are given in Table S3 (Supporting Information).
None of the observed effects exceeds the Bonferroni thresh-
old of 2.3 · 10
)5, although CORO1A (coronin) comes quite
close. Nine of the ten strongest associations of age-adjusted
expression with mortality are negative, meaning that relative
overexpression of the gene is associated with reduced mortal-
ity. Interestingly, the one exception is TERF2IP (telomeric
repeat binding factor 2, interacting protein), which is thought
to protect telomeric DNA from nonhomologous end-joining.
Note that only one gene (CORO1A) appears in both Tables 1
and 2, supporting the notion that gene expressions strongly
associated with age at blood draw are not necessarily strongly
associated with survival, too. As in Table 1, most of the esti-
mated heritabilities in Table 2 are 0.25 or greater, while
CORO1A is again highest (0.66). No evidence for heritability
of expression was seen for TERF2IP, KIF2C, or EMP3. We
observed moderately strong positive spouse correlations for
IQGAP1 (0.22) and CORO1A (0.23).
A total of 167 (7.8%) expression levels were associated
with survival in the CEU grandparents at a nominal P < 0.05.
Of these, 48 were associated with age at blood draw at a
nominal P < 0.05. Table S2 (Supporting Information) shows
complete results for the 2151 always-expressed genes.
Combining information on age at draw and survival
after draw
The results shown in Tables 1 and 2 have limited power rela-
tive to the large number of comparisons because expression
data were available for only 104 grandparent samples. How-
ever, both the association of age with expression level, and
the association of expression level with survival after blood
draw, contains distinct and important information about the
relationship of gene expression to aging in humans. We used
two strategies to combine these pieces of information (see
Methods, below): (i) a test of the joint null hypothesis that
expression is related to neither age nor survival; and (ii) a
two-stage model that constructs a multivariate estimator of
biological age, then uses it to predict survival. We describe
these results below.
Tests of the joint hypotheses that expression is
related to neither age nor survival
Figure 1 shows the relationship between Z-scores for age
effects and survival effects on (age-adjusted) expression levels,
for the CEU grandparents. Using Fisher’s likelihood ratio
approach (Fisher, 1932), we compare the observed Z-scores
Table 2 Top 10 survival-associated expression levels in CEU grandparents
HG-focus
probeset
Gene
symbol ZP -value H
2
Spouse
correlation
HF7873 CORO1A )4.20 2.64E)05 0.66 0.23
HF8664 IQGAP1 )3.60 3.19E)04 0.59 0.22
HF6054 AURKB )3.58 3.41E)04 0.34 )0.04
HF7038 TERF2IP 3.37 7.45E)04 0.064 0.0089
HF6482 CBX5 )3.37 7.46E)04 0.41 )0.058
HF8349 KIF2C )3.35 8.02E)04 0.046 0.035
HF657 ACTR2 )3.27 1.07E)03 0.45 0.068
HF2735 SPAG5 )3.21 1.31E)03 0.39 )0.012
HF2854 MTF2 )3.17 1.54E)03 0.25 0.040
HF7574 EMP3 )3.13 1.74E)03 0.068 )0.0026
Probeset, probeset name from HG-focus refseq transcript library [see
reference (Liu et al., 2007)]; gene symbol(s), HUGO symbol name or names
corresponding to current mapping of probeset sequence; Z, Z-score from
proportional hazards model of survival vs. age-adjusted expression; P-value,
probability of observing a Z greater than that observed; H
2, heritability.
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Fig. 1 The standardized linear effect of age on each of 2151 expression
levels among 104 CEU grandparents is plotted on the x-axis against the
standardized effect of each expression level on mortality (log hazard rate
ratio). Larger red dots indicate the observed values; smaller black dots
represent values generated over 100 of the 1000 random permutations of
the phenotypic (age, sex, and survival) data associated with each
expression vector. Positive values on the x-axis indicate increased expression
with increasing age; negative values indicate decreased expression with
increasing age. Positive values on the y-axis indicate increased mortality risk
with increased expression; negative values indicate decreased risk. The
dashed line is drawn at the 50th largest v
2 value observed in 1000
permutations of 2151 genes.
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241(large red dots) to those generated by a 10% sample of 1000
random permutations of the phenotypic (age, sex, and sur-
vival) data, while keeping the expression vectors constant
(small black dots). The dashed ellipse is drawn at the 50th
largest chi-squared value observed for the 2151 always-
expressed genes and 1000 permutations. The results are
shown this way to approximate the ﬁfth percentile of the null
distribution, adjusted for 2151 comparisons. Three genes fall
outside the threshold: CORO1A (0%), CDC42 (0.2%), and
AURKB (aurora kinase B; 1.5%). Expression of CDC42
increases with age among the CEU grandparents, and higher
age-adjusted expression is associated with higher mortality.
CORO1A and AURKB represent the opposite extreme of this
same pattern: expression decreases with age, and higher age-
adjusted expression is associated with lower mortality.
Overall there is a fairly strong positive correlation (r = 0.51;
P < 2.2 · 10
)16) between Z-scores for age-related expression
change and age-adjusted survival in Fig. 1. The orientation of
this general pattern is described by the contrast between
CORO1A in the lower left quadrant, and CDC42 in the upper
right quadrant. Points located in the lower left quadrant (e.g.
CORO1A) represent expression levels that decrease with age,
and where relative underexpression is associated with higher
mortality. Points located in the upper right quadrant (e.g.
CDC42) represent expression levels that increase with age, and
where relative overexpression is also associated with higher
mortality. In contrast, the randomly permuted data are
distributed roughly equally around the origin, including many
points in the upper left and lower right quadrants. The
observed distribution includes relatively few points in these
quadrants, and none near the extremes of the null distribution.
It is likely that the results shown in Fig. 1 do not fully illumi-
nate all the patterns of age-related changes in gene expres-
sion and survival. Given that cross-sectional data were used to
estimate longitudinal patterns of gene expression, we might
worry that particular age-related trends in expression are con-
founded by differential survival, which could cause expressions
that do not change with age to appear to do so, or mask true
patterns of change. Associations of this type should occur in
the upper left or lower right quadrants of Fig. 1, because a
positive relationship between expression and mortality should
be associated with apparently declining expression, while a
negative relationship should be associated with apparently
increasing expression.
It is also possible to imagine examples of upper left and lower
right quadrant effects with a biological basis. For example,
expressions that reﬂect damage repair or detoxiﬁcation pro-
cesses might rise with age and overexpression of these genes
might be beneﬁcial to longevity. However, our results offer no
persuasive evidence that such associations are very common.
Multivariate models of biological age vs. survival
It is perhaps intuitively less appealing to examine the associa-
tion of variation in gene expression for complex traits one
gene at a time, than to allow all measured genes to compete
with one another simultaneously for inclusion in a model that
adjusts for correlations among expression levels. If the number
of samples were larger than the number of genes considered,
standard multiple linear regression methods might be a suit-
able approach to this problem. However, like most studies
involving microarray data, we have many more potential
predictor variables than independent samples. Numerous
approaches to the problem of more dimensions than data
points have been proposed, but many of them sacriﬁce inter-
pretability because they collapse correlated expression pat-
terns into composite variables without regard to biological
plausibility. Penalized regression approaches can be
interpreted much the same as multiple linear regression
because they preserve the original data; overﬁtting is avoided
by incorporating a ‘regularization parameter’ that penalizes
the likelihood function according to the number of terms in
the model. Several different penalized regression schemes
have been proposed, including ridge regression (Hoerl & Ken-
nard, 2000), bridge regression (Frank & Friedman, 1993), and
the LARS⁄LASSO (for least angle regression⁄least absolute
shrinkage and selection operator) family of approaches devel-
oped by Efron et al. (2004).
In the Methods section, below, we describe estimation and
cross-validation procedures for the LASSO model of biological
age. Figure 2a shows the leave-one-out cross-validation (LOO-
CV) curve observed over the ﬁrst 40 steps (black line), com-
pared to LOOCV curves generated under 100 random
permutations of the phenotypic data. In Fig. 2b the blue line
plots the probability, at each step, that a model generated
from random data has a mean-squared error (MSE) as low as
the observed model; the red line plots P-values generated by
proportional hazards regression using the biological age esti-
mate as a predictor of mortality. It is clear from Fig. 2a,b that
the observed LOOCV curve is below the ﬁfth percentile of the
distribution of random curves by step 14, and the observed
curve remains lower than any randomly generated curve for
all steps after step 28. Meanwhile, the predicted biological
age generated from the observed model is strongly signiﬁ-
cantly related to survival after blood draw from steps 2 to 30.
The estimated MSE at step 14 is 57, corresponding to a pre-
diction error of ± 7.6 years (7.4 years at step 28). Figure 2c
shows the slope coefﬁcients at steps 14 and 28.
The most parsimonious model with an MSE lower than
95% of simulations occurs at step 14. Coefﬁcients of the
model, in decreasing order of absolute value, are: CDC42
(5.5), SEPT2 (1.6), PBX3 (1.1), CIB1 ()0.91), SH3BGRL (0.77),
UBE2A ()0.71), RNH1 ()0.60), PPP1R11 (0.55), QDPR ()0.48),
DDX24 (0.36), GINS2 ()0.30), LPXN (0.24), and ACAA1
(0.16). Clearly, the positive association of CDC42 with age at
draw dominates this model. This remains true at steps 20, 40,
60, and 80 (data not shown). Expression levels of CDC42,
SH3BGRL, QDPR, and RNH1 were also among the ten most
strongly associated with age at draw for CEU grandparents in
the univariate analysis reported in Table 1. In the LOOCV
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242models, all the selected terms were included over 85% of the
time at step 14, with the exception of LPXN (39%), DDX24
(4%), and ACAA1 (0%).
We used the step 14 model from Fig. 2c to generate esti-
mated biological ages for the CEU grandparents, then include
them together with chronological age at draw and sex, in a
proportional hazards model of survival. As expected, predicted
biological age was positively associated with mortality. The
hazard rate ratio (an estimate of relative risk) for a single year
increase in estimated biological age was 1.33 (95% CI: 1.10–
1.62).
An alternative approach to modeling survival as a function
of estimated biological age would be to model it as a function
of the difference between biological and chronological age.
This is equivalent to forcing both biological age and chrono-
logical age to have the same slope (with opposite signs), and
is efﬁcient only if both variables are scaled identically. We
evaluated this approach by rescaling biological age to have 0
mean and unit variance, then multiplying by the standard
deviation of chronological age (7.9) and adding the mean
chronological age (71.5); that technique produced results (not
shown here) essentially identical to our original method,
reported above.
Multivariate models of survival vs. expression level
The above analysis demonstrates that biological age, esti-
mated from gene expression levels that change with age, is a
signiﬁcant predictor of remaining life span. An important
potential weakness of this analysis is that it places too much
emphasis on gene expressions that vary systematically with
age in cross-sectional data. As noted above, the confounding
of differential survival effects with age-related changes in
expression could mask the effects of genes that regulate or
contribute to survival.
In an effort to circumvent this limitation, we also applied the
LASSO approach to model survival as a direct multivariate func-
tion of expression levels. We computed deviance residuals from
a baseline survival model adjusted for age at draw and sex, and
used LASSO to identify expression levels associated with
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Fig. 2 Least absolute shrinkage and selection
operator model of biological age. At each step,
an additional gene may be added to or
subtracted from the model. (a) Mean square
classiﬁcation error (MSE) estimated by cross
validation, for the observed data (black line), and
100 random permutations of phenotype data
(blue lines); (b) probability of observing MSE less
than or equal to the observed MSE (blue), and
P-value of biological age estimate as a predictor
of mortality (red); dashed line is 0.05; (c) slope
estimates for gene expressions included in the
14-step model (solid bars), and the 28-step model
(hashed bars), showing how the estimated effect
of a gene changes as more genes are added to
the model. All models between steps 14 and 28
are both signiﬁcantly better at estimating
biological age than models based on random data
and signiﬁcantly better at predicting future
mortality than models based on age and sex
alone.
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243variation in the deviance residual [see Methods and reference
(Segal, 2006)]. We used the same permuted LOOCV approach
for cross validation and permutation tests of signiﬁcance
(described above and in Methods). Results are shown in Fig. 3.
Figure 3a shows the cross-validation results compared to
results of 100 random permutations of the phenotype data; a
minimum is reached at step 7. In Fig. 3b, the observed cross-
validation MSE was smaller than 94% of those observed in
permuted data at step 7. Model coefﬁcients are in order of
decreasing absolute value: CORO1A ()0.27), FXR2 (0.21),
CBX5 ()0.074), PIK3CA ()0.0094), AKAP2 ()0.0086), and
CUL3 ()0.0081). The model is dominated by the positive asso-
ciation between FXR2 expression and mortality, and the nega-
tive association between CORO1A expression and mortality.
Negative associations of AKAP2, CUL3, CBX5, and PIK3CA
with mortality also contribute to the model. Table 3 shows
that the linear predictors generated by this model are strongly
associated with survival: P-value = 4.0 · 10
)8; inter-quartile
relative risk (IQRR) = 2.35; median estimated survival differ-
ence = 5.5 years. Predicted mortality from the model
accounts for 23% of the variation (R
2 = 0.23) in survival
among the CEU grandparents. Model coefﬁcients for individ-
ual genes are converted into IQRR in Fig. 3c and plotted on a
log scale.
The nominal P-value given in Table 3 for the overall data is
very low, but unsurprising, given that the same survival data
were used for estimation and testing. Evaluating the ability to
predict survival in selected subgroups (e.g. males vs. females,
for various causes of death, or varying numbers of years after
blood draw) may be more informative than showing how well
the model ﬁts the overall data. Table 3 shows that the model
predicts similar mortality risks for males and females. As age
is the single largest risk factor for multiple life-threatening dis-
eases, a biomarker that truly reﬂects biological age (or rate of
aging) should be associated with risks of dying from not one,
but several common causes of death due to age-related dis-
eases. Therefore, we tested the panel of gene expressions
from the survival model (LASSO) for associations with mortality
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Fig. 3 Least absolute shrinkage and selection
operator model of survival. At each step, an
additional gene is added to or subtracted from
the model. (a) Mean square classiﬁcation error
(MSE) estimated by cross validation, for the
observed data (black line), and 100 random
permutations of phenotype data (blue lines);
(b) probability of observing MSE less than or equal
to the observed MSE (blue), and P-value of overall
model as a predictor of mortality (red); dashed
line is 0.05; (c) estimated interquartile relative
risks for terms included at step 7, showing the
estimated effect of a typical variation in gene
expression on the relative risk of dying. Models
with between four and eight genes included are
better at predicting future mortality than 90% of
models generated from random data, with a
minimum P-value of 0.06 at step 7.
Gene expression proﬁles associated with aging and mortality, R. A. Kerber et al.
ª 2009 The Authors
Journal compilation ª Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland 2009
244risks for the common causes of death. Table 3 shows that the
LASSO model predicts risk from multiple causes of death, in
spite of very small sample sizes, with a particularly strong (but
imprecisely estimated) effect for deaths attributed to diabetes.
It is worth noting that the number of causes of death listed in
Table 3 (6) is larger than the number of genes contributing
importantly to the model (3), so the possibility that these
associations are caused by overﬁtting seems slight.
Table 3 also shows that the LASSO model remains strongly
predictive of mortality for at least 10 years following blood
draw. Thus, these associations are not likely due to the pres-
ence of terminal diseases in some research subjects at the
time of enrollment in the study.
Although Table 3 demonstrates that the predicted model is
not strongly affected by subgroup inﬂuences on gene expres-
sion, a more robust assessment of whether the ﬁt of the
model was produced by chance is given by the permutation
distribution of cross-validation curves shown in Fig. 3b. The
minimum cross-validation MSE of the model is smaller than
94% of those generated by random permutation of the phe-
notype data (step 7). Therefore, there is approximately a 6%
probability that the LASSO model of survival, based on 2151
measures of gene expression, ﬁts our data this well by
chance.
Environmental exposures
Inter-individual differences in gene expression proﬁles in the
Utah CEU lymphoblastoid cell lines may reﬂect not only heri-
table genetic inﬂuences, but also environmental exposures
experienced at any time prior to blood draw. Therefore, we
considered the possibility that gene expressions associated
with survival may simply reﬂect exposures (or nonexposure) to
a common toxic agent, such as cigarette smoke. The data
available to us do not contain information on environmental
exposures; however, afﬁliation with the Church of Jesus Christ
of Latter-day Saints (or LDS church), available from the UPDB,
indirectly provides information about exposures that affect
mortality risks. Merrill et al. (2003) using data from the 1996
statewide Utah Health Status Survey, report that 9.2% of LDS
men (vs. 24.5% of non-LDS Utah men) reported being current
smokers, while only 4.1% of LDS women reported smoking
(vs. 23.1% of non-LDS women). Of the 104 grandparents
with expression data who linked to the UPDB, 77 (74%) were
strongly afﬁliated with the LDS church, and this is probably an
underestimate because UPDB data are very incomplete in this
regard. We thus would expect only a small number (probably
less than ten) of the grandparents to have been smokers.
In previous work with the UPDB, we have shown that reduced
smoking and alcohol consumption among active church mem-
bers probably accounts for 1.3 additional years of life expec-
tancy compared to Utahans unafﬁliated or inactive in the
church (Kerber et al., 2001). Inclusion of church afﬁliation as
a covariate in the survival models slightly strengthens the rela-
tionship of the model predictions to survival (data not shown),
indicating that the results reported in Table 3 are not con-
founded by smoking. Furthermore, none of the genes listed in
Table 2, or included in the LASSO survival model, have been
reported to be signiﬁcantly affected by cigarette smoking
(Ryder et al., 2004; van Leeuwen et al., 2005).
It is apparent in Tables 1 and 2 that spouse correlations for
some individual gene expressions are moderately high. Across
the entire set of 2151 always-expressed genes, the highest
observed spouse correlation is 0.50 (PRSS3). CORO1A and
IQGAP1 exhibit spouse correlations > 0.2, although the
estimated heritability for each is quite high. The mean spouse
r
2 across the entire dataset is 0.962 while the maximum r
2 for
100 random pairs of grandparents was slightly smaller (0.958;
minimum = 0.952, mean = 0.955). Overall, then, spouse
expression proﬁles are slightly more strongly correlated than
Table 3 Performance of LASSO mortality model by sex, cause of death, and time since blood draw
Subset At risk Deaths IQRR ZP -value
Median survival
1st quartile
Median survival
4th quartile
All 104 72 2.35 5.49 4.0E)08 89.3 83.8
Males 52 40 2.73 3.76 0.00017 90.5 81.7
Females 52 32 2.31 3.99 6.6E)05 88.8 84.7
Cause of death
Heart 104 19 2.17 2.65 0.0080
Cancer 104 14 2.37 2.14 0.032
Stroke 104 11 3.73 3.54 0.00040
Diabetes 104 5 7.72 3.21 0.0013
Inf ⁄ Pneu 104 5 3.48 2.49 0.013
Cognitive 104 10 2.57 2.12 0.034
Years after blood draw
1 103 71 2.35 5.46 4.8E)08 89.1 82.6
3 95 64 2.27 4.75 2.0E)06 89.4 84.6
5 88 57 2.53 4.27 2.0E)05 90.4 85.2
10 72 41 2.41 3.30 0.00097 91.5 88.1
IQRR, relative risk comparing the 75th percentile of estimated risk (0.21) to the 25th percentile ()0.03), adjusted for actual age and sex; median survival 1st
quartile, estimated median survival for subjects at the 25th percentile of estimated risk (adjusted for age and sex); median survival 4th quartile, estimated
median survival for subjects at the 75th percentile of estimated risk (adjusted for age and sex).
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245expected by chance, although the level of correlation among
all expression proﬁles is very high. Interestingly, however, the
correlation of mortality risk between spouses (using the
deviance residuals from the baseline proportional hazards
model – see Methods) is only 0.075 (P-value 0.45), so
correlations in expression are not likely to confound the sur-
vival analysis.
Discussion
It is not surprising to ﬁnd that gene expression patterns vary
with age, nor that variation in gene expression correlates with
variation in longevity; many studies in model organisms have
clearly demonstrated these associations. However, the obser-
vation that patterns of gene expression in lymphoblastoid cell
lines contain information about both the age and subsequent
survival of human donors is both biologically interesting and
potentially of great clinical utility.
While Fig. 1 shows clearly that, in general, the intensity and
direction of age-related change in expression of a gene among
the CEU grandparents is related to the strength of association
of that gene’s expression with survival, identifying individual
genes that are most strongly related to aging is less simple. We
have taken a variety of approaches to this task, and several
genes appear to be important in more than one context. In par-
ticular, CDC42 and CORO1A appear to be associated with both
age at draw and survival after blood draw, whether univariate
or multivariate approaches are applied. CDC42 expression
increases with increasing age among the CEU grandparents,
and, after adjusting for age, higher expression of CDC42 is
associated with higher mortality. CDC42 is also the dominant
factor in our multivariate model of biological age, which is a sig-
niﬁcant predictor of mortality. Recently, Wang and colleagues
reported that mice deﬁcient in a negative regulator of Cdc42
(Cdc42GAP) exhibited constitutively elevated Cdc42 expression
and phenotypes consistent with premature aging, including:
osteoporosis, muscle atrophy, and impaired wound-healing.
According to Wang et al.:
‘‘Our ﬁndings that Cdc42 activation is associated with natu-
ral aging and that Cdc42GAP deﬁciency causes a DNA dam-
age repair defect to allow cells to accumulate genomic
abnormalities that leads to early senescence further suggest a
functional link between Cdc42 activity and mammalian aging
(Wang et al., 2007).’’
The results of this study support this conclusion.
Coronin (CORO1A) is an actin-binding protein with poten-
tially important functions in both T-cell mediated immunity
and mitochondrial apoptosis (Dustin, 2006; Foger et al., 2006;
Mueller et al., 2008). Shiow et al. (2008) report that coronin
defects in mice cause peripheral T-cell deﬁciency, and describe
a human patient with severe combined immunodeﬁciency
who had mutations in both coronin alleles. A nonsense muta-
tion in CORO1A has recently been shown to suppress
autoimmune response in a mouse model of systemic lupus
erythematosus (Haraldsson et al., 2008), further suggesting
that coronin is critical to immune functioning. Moreover, the
inadvertent coronin knockout mice of Haraldsson et al. show
substantially decreased mitochondrial membrane potential
and increased apoptosis in T cells, but not in B cells.
Several other genes exhibiting associations with either aging
or survival are worthy of note. AURKB is a key member of the
chromosomal passenger complex which is critical in the regu-
lation and conduct of mitosis (Ruchaud et al., 2007). Inhibi-
tion of AURKB in tumor cells leads to growth inhibition and
apoptosis (Yang et al., 2007). CBX5 encodes the human HP1a
heterochromatin protein, importantly involved in the construc-
tion and maintenance of chromatin and hence an important
regulator of gene expression. CBX5 expression decreases with
age in the CEU grandparents, and reduced expression is asso-
ciated with greater mortality. Likewise, reduced expression of
IQGAP1 is associated with increased mortality, although
expression of IQGAP1 is not strongly related to age. Interest-
ingly, IQGAP1 is an effector of CDC42, and is involved in mul-
tiple signaling pathways (Brown & Sacks, 2006). Goring et al.
(2007) report a LOD score for cis-regulation of IQGAP1
expression of 5.8 (chromosome 15, 99 cM). Similarly, we ﬁnd
that, in the 60 CEU grandparents genotyped by the
International HapMap Projects (http://www.hapmap.org), sev-
eral single nucleotide polymorphisms near the IQGAP1 gene
are strongly associated with IQGAP1 expression (rs1702161,
rs3862432, rs3862435, and rs3862436).Thus, the region
immediately surrounding IQGAP1 may harbor genetic variants
associated with variation in human lifespan.
It is puzzling that relative overexpression of TERF2 interact-
ing protein (TERF2IP, aka hRAP1) in lymphoblastoid cell lines is
associated with increased mortality, because increased expres-
sion of TERF2IP should lead to increased telomere length (Li &
de Lange, 2003), which has been associated with decreased
mortality in the CEU grandparents (Cawthon et al., 2003).
Unlike IQGAP1, variation in TERF2IP expression is not highly
heritable, either in transformed (H
2 = 0.09; P = 0.10 in our
data) or untransformed (H
2 = 0.15; P = 0.054 in Goring
et al., 2007) lymphocytes. In fact, TERF2IP expression was
uncorrelated with subjects’ telomere lengths as measured in
whole blood (r = 0.04). This may be a consequence of the cell
transformation process, which activates telomerase so that cell
lines may grow indeﬁnitely in culture; possibly variable TER-
F2IP expression is marking some variation in telomerase activ-
ity in transformed lymphocytes that is indirectly related to
longevity. A recent report links longer telomeres to increased
risk of breast cancer (Svenson et al., 2008). Among the CEU
grandparents, however, TERF2IP expression was not signiﬁ-
cantly associated with cancer mortality risk.
Because of the large number of comparisons we have gener-
ated for a relatively small number of samples, and because the
potential for measurement error is inherent in microarray data,
the associations we have observed require conﬁrmation in
other settings. Associations between gene expressions and
survival may be due to causal roles in regulating aging; alter-
natively, the expression of a gene may not reﬂect a regulatory
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246role in aging, but nevertheless may serve as a reliable indicator
of overall health and remaining life expectancy. Strong evi-
dence for a regulatory role in aging would be provided by
experiments in model systems showing that modulating
expression extended lifespan. Within the CEU family data, we
are pursuing linkage and genetic association studies to identify
loci responsible for regulating expression of the heritable
expression phenotypes associated with longevity. The identiﬁ-
cation of germ line variants that affect the expression of lon-
gevity-associated genes will facilitate further high-throughput
genetic epidemiologic studies of human aging. However, even
the nonheritable gene expression patterns we have reported
may have considerable relevance to mechanisms of aging and
age-related disease processes. Finally, we note that expression
data are available for approximately 6000 genes not included
in the ‘always-expressed’ list to which we restricted this analy-
sis. Approximately half of these genes are expressed in many,
but not all samples. The other half are rarely, if ever, expressed
above background. We plan to investigate the association
between longevity and expression of these genes as well.
We have described some striking patterns of association of
gene expression with age and mortality, based on lymphoblas-
toid cell lines derived from ordinary blood samples, and stored
for years as a replenishable source of DNA for genetic studies.
If these results can be conﬁrmed by others, frozen cell lines
may also have considerable value as sources of phenotypic
information on transcription, translation, and other cellular
processes helpful in predicting the future health of the donors.
Materials and methods
The CEPH⁄Utah family resource originated from bloods drawn
from 46 three-generation families, each consisting of 5–15
siblings, their two parents, and two to four grandparents who
were still alive at the time of the family blood draws in the
early 1980s (White et al., 1985; Dausset et al., 1990). All sub-
jects signed written forms giving informed consent for sam-
ples to be used in health research on the condition that
names were not to be released in reports or published. The
University of Utah IRB has approved this research project.
Cheung and co-workers (Cheung et al., 2003, 2005; Morley
et al., 2004) extracted RNA from transformed B lymphocytes
obtained from the Coriell Cell Repository (http://locus.
umdnj.edu/nigms/ceph/ceph.html) for a total of 247 CEU
family members (124 male; 123 female), including 104 of the
grandparents for whom we had survival data. Expression
levels for 8793 probesets were measured using Affymetrix
HG-Focus arrays. The resulting expression data were deposited
in the NCBI Gene Expression Omnibus database, accession
numbers GSE1485 and GSE2552. We combined both datasets
to maximize the number of individuals available for study.
Each probeset on the HG-Focus array consists of a set 11–
20 pairs of probes, each consisting of a 25-mer oligonucleo-
tide representing a ‘perfect match’ to the target sequence
and a ‘mismatch’ probe made by substituting an alternative
nucleotide at the 13th position. Several recent studies
(Mecham et al., 2004; Dai et al., 2005; Liu et al., 2007) have
shown that the original mapping of probes and probesets to
genes, based on the human UniGene Build 133 database,
contains many errors. To improve the ﬁt of probesets to
genes, we used the ‘HG-Focus RefSeq Transcript’ mapping
supplied by Liu et al., available from http://gauss.dbb.george-
town.edu/liblab/affyprobeminer/transcript.html. After re-map-
ping, 8174 probesets were available for analysis.
We tested whether each gene was expressed beyond base-
line in each sample using the Wilcoxon signed rank test as
described in the Affymetrix Microarray Suite version 5 (Liu
et al., 2002). This is a test for absolute ‘presence’ vs.
‘absence’, testing if the observed signals for each probeset
were signiﬁcantly greater than background. For purposes of
the present analysis, we eliminated from consideration all
probesets that were not called ‘present’ (P < 0.04) or ‘mar-
ginal’ (P < 0.06) in each of the grandparents’ samples. This
step left us with 2151 always-expressed genes.
We used Wu and Irizarry’s GeneChip robust multiarray aver-
aging (GCRMA) method to normalize all expression levels(Wu &
Irizarry, 2005). The GCRMA and MAS 5.0 algorithms we
employed were implemented in the ‘affy’ and ‘gcrma’ pack-
ages available from the Bioconductor website (http://
www.bioconductor.org).
We evaluated all samples for outlying observations in rela-
tion to average background, scale factor, number of genes
called ‘present’, and 3¢ to 5¢ ratios for GAPDH, following the
procedures described by Wilson et al. (2004). We excluded 12
samples from analysis because they were out-of-range for at
least one test. In addition, ﬁve samples exhibited inappropri-
ately high or low levels of expression of both RPS4Y1,
encoded on the Y chromosome, and the X-inactivating
sequence transcript (XIST), expressed only in women. Without
exception, in women high expression of RPS4Y1 was coupled
with low expression of XIST, and in men low expression of
RPS4Y1 was coupled with high expression of XIST. As all
grandparents are by deﬁnition fertile, we could rule out sex
chromosome abnormalities as an explanation. We excluded
these samples on the grounds that they had been mistakenly
attributed to the wrong person. After these exclusions, at
least one sample from 238 individuals (including all 104
grandparents) remained.
Many CEU family members, including most of the grand-
parents, had expression data available from multiple arrays
(usually two, although two of the grandparents had four
arrays available). For these individuals, we averaged gcrma-
corrected expression levels for each probeset prior to analysis.
Univariate analyses
We performed two separate analyses of expression as a
function of age at draw. First, we considered only the grand-
parents, who were effectively unrelated to one another,
although careful analysis of the records of the UPDB (Wylie
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247& Mineau, 2003) has revealed that a few of the CEU grand-
parents are distantly related. The grandparents’ expression
data represented were treated as independent observations,
and we used ordinary least squares methods to regress
expression level for each of the always-expressed probesets
against age, adjusting for sex. Zhang et al. (2007) have
already reported on patterns of sex-speciﬁc expression in
these data.
Strong genetic correlations in expression level should be
present within each three-generation CEU family. For this rea-
son, standard linear regression approaches are not appropri-
ate for the study of age-related variation in expression
patterns. Instead, we used linear mixed-effects models to
adjust for the kinship among family members (Therneau,
2007). The substantially larger sample size (238 vs. 104) and
wider range of ages at draw (5–97 vs. 57–97) led us to con-
sider both linear and quadratic effects for age at draw in the
three-generation families. Otherwise, the model ﬁt was the
same as for the grandparents: expression level was modeled
as a function of age at draw, age squared, and sex. Heritabil-
ity estimates were computed for three-generation pedigrees
using SOLAR (Almasy & Blangero, 1998). These results are
given in Tables S1 and S2 (Supporting Information).
Survival models
Grandparents ranged in age from 57 to 97 years of age at
the time of the blood draw. Median follow-up age was
84.7 years (range 65.7–100.8). Survival was measured from
age at draw to age at death or follow-up. We used a propor-
tional hazards model adjusting for sex, year of birth, and age
at draw to test the association of each expression level with
survival. Each proportional hazards model was tested for non-
proportionality using the cox.zph function in the R software
package (http://www.r-project.org). Although some nonpro-
portionality was detected with P-values below 0.0001, none
of the genes strongly associated with survival had a P-value
for nonproportionality lower than 0.28 (EMP3).
Bivariate age-at-draw vs. survival models
We computed Fisher’s (1932) likelihood ratio test of the com-
posite null hypothesis that expression was unrelated to either
aging or longevity. We generated 1000 random permutations
of the survival data because of concerns that age at blood
draw was not completely independent of survival after blood
draw, even under the null hypothesis. Random permutations
were generated by shufﬂing the rows of a matrix that
included age at draw, age at follow-up, sex, and vital status
as columns. For each iteration, the randomly ordered pheno-
types were assigned to the unpermuted gene expression vec-
tors, and computed the linear regressions on age at draw,
the proportional hazards models and the Fisher test. This pro-
cedure allowed the correlation structure of the expression
data, and the correlation structure of the survival data to
remain intact, while testing the relationship between the two
datasets.
Adjustment for multiple comparisons
Adjustments for multiple testing are clearly appropriate in this
context, but many methods mask hidden assumptions about
the dependency structure of the data or the true proportion
of false null hypotheses (Reiner et al., 2003). Even permuta-
tion-based methods may retain some vulnerability to hidden
dependencies within microarray data (Efron & Tibshirani,
2007). We therefore employ a simple Bonferroni correction in
presenting the results of the univariate analyses, and a Monte
Carlo permutation test in presenting the results of the
bivariate analyses.
Multivariate analyses
LASSO models of biological age
To assess the relationship between age at draw and multiple
expression levels, we employed the LASSO algorithm of Tibsh-
irani (Tibshirani, 1996; Efron et al., 2004) to build a linear
model of age at draw as a function of multiple expression lev-
els. We used only the grandparents’ data to avoid complex
dependency structures. Brieﬂy, the LASSO approach minimizes
the residual sum of squares in a multiple regression model
subject to the constraint that the sum of the absolute values
of the standardized coefﬁcients is less than a speciﬁed con-
stant. Efron et al. (2004) showed that computing all possible
LASSO models is feasible and provides a basis for rationally
choosing among them, by minimizing Cp or by cross
validation.
Cross-validation procedures divide the data at random into
K equal subsets, and, for i =1t oK, use all the data not in
the ith subset to estimate the model, and the data in ith sub-
set to test the model predictions. The goal is to ﬁnd the value
of the tuning parameter that minimizes the mean square pre-
diction error across the K subsets. With relatively small data-
sets, however, K-fold cross-validation procedures are often
unstable (Segal, 2006) – this proved to be the case with the
present data set.
We set K = 104, which leads to the LOOCV procedure
(LOOCV) in our sample of 104 grandparents. We compared
the resulting LOOCV curve to curves generated from 100 ran-
dom permutations of the data, performed as described above.
Comparing the cross-validation curve to a null distribution of
cross-validation curves not only gives information on the opti-
mal setting of the tuning parameter, but also on the probabil-
ity that the result is due to chance.
For each value of the tuning parameter, corresponding to a
step in which a predictor variable can be added or dropped,
the model selected was used to predict each subject’s age at
draw. These ‘biological age’ estimates, together with the sub-
jects’ actual age and sex, were used to predict age at death
in a proportional hazards model.
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248LASSO models of survival after blood draw
We followed the approach of Segal (2006), using the LASSO
approach described above to regress the deviance residuals of
a baseline proportional hazards regression (adjusted for sex
and age at draw) against the set of expression levels. These
permuted LOOCV approach described above to identify opti-
mal settings for the tuning parameter and to assess the prob-
ability that the observed pattern was the result of chance.
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